| Pharmaceutical active ingredients: |
| Nitrofurazone |
| Available forms, composition and doses of Furacin-Sol: |
| N / A |
| Furacin-Sol medical category: |
| Human:AntiinfectivesTopical antibioticsTreatment of eye infections |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B05CA03 - NitrofuralD08AF01 - NitrofuralD09AA03 - NitrofuralP01CC02 - NitrofuralS01AX04 - NitrofuralS02AA02 - Nitrofural |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bioglan |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Furacin-E | Nitrofurazone | Unidentified Pharmaceutical Company |
| Furacinetten | Nitrofurazone | Unidentified Pharmaceutical Company |
| Furacin-HC | Nitrofurazone | Unidentified Pharmaceutical Company |
| Furacin-Otalgicum | Glycerol; Nitrofurazone; Phenazone; Tetracaine Hydrochloride | Rohm Pharma |
| Furacin-S | Hydrocortisone Acetate; Nitrofurazone | GlaxoSmithKline |
| Furacoccid | Nitrofurazone | Unidentified Pharmaceutical Company |
| Furacort | Nitrofurazone | Unidentified Pharmaceutical Company |
| Furacycline | Nitrofurazone | Unidentified Pharmaceutical Company |
| Furadantin | Nitrofurantoin | Elan Pharmaceuticals; Allphar Services; First Horizon Pharmaceutical; Formenti Farmaceutici; GlaxoSmithKline; Goldshield Pharmaceuticals; Nordend-Apotheke Dr. Wolfgang Hotz; Norwich Pharmaceuticals; Nycomed; Pfizer; Procter & Gamble; Recip, Sweden; Sciele Pharma; Shionogi |
| Furadantin Retard | Nitrofurantoin | Boehringer Ingelheim; Procter & Gamble; Vifor Pharma |